We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
4 similar Stock Option Agreement contracts by OphthaliX, Inc.
Made as of the 1 day of July, 2013Stock Option Agreement • July 2nd, 2013 • OphthaliX, Inc. • Pharmaceutical preparations
WHEREAS, on February 2, 2012 the shareholders of the Company approved the 2012 Stock Incentive Plan, a copy of which is attached as Exhibit A hereto (the "Plan"), on January 29, 2013 the Board of Directors of the Company has approved the Israeli Annex to the Plan to enable the grant of Options under Section 102 of the Israeli Tax Ordinance ("Section 102"), a copy of which is attached as Exhibit A hereto, forming an integral part hereof (the “ISOP”; the Plan and the ESOP shall collectively be referred to herein as the "ESOP"), on July 1, 2013 the Board of Director of the Company has resolved to grant to the Optionee an Option to purchase up to 235,000 Common Stock of the Company (collectively, the "Shares") in accordance with the terms of the ESOP; and
Standard Contracts
Made as of the 28 day of April, 2013Stock Option Agreement • June 18th, 2013 • OphthaliX, Inc. • Pharmaceutical preparations
WHEREAS, on February 2, 2012 the shareholders of the Company approved the 2012 Stock Incentive Plan, a copy of which is attached as Exhibit A hereto (the "Plan"), on January 29, 2013 the Board of Directors of the Company has approved the Israeli Annex to the Plan to enable the grant of Options under Section 102 of the Israeli Tax Ordinance ("Section 102"), a copy of which is attached as Exhibit A hereto, forming an integral part hereof (the “ISOP”; the Plan and the ESOP shall collectively be referred to herein as the "ESOP"), and on April 22, 2013 the Board of Director of the Company has resolved to grant to the Optionee a Time Based Option to purchase up to 469,854 Common Stock of the Company and a Success Based Option to purchase up to 469,854 Common Stock of the Company (collectively, the "Shares") in accordance with the terms of the ESOP; and
Made as of the 13 day of June, 2013Stock Option Agreement • June 18th, 2013 • OphthaliX, Inc. • Pharmaceutical preparations
WHEREAS, on February 2, 2012 the shareholders of the Company approved the 2012 Stock Incentive Plan, a copy of which is attached as Exhibit A hereto (the "Plan"), on January 29, 2013 the Board of Directors of the Company has approved the Israeli Annex to the Plan to enable the grant of Options under Section 102 of the Israeli Tax Ordinance ("Section 102"), a copy of which is attached as Exhibit A hereto, forming an integral part hereof (the “ISOP”; the Plan and the ESOP shall collectively be referred to herein as the "ESOP"), and on May 29, 2013 the Board of Directors of the Company has resolved to grant to the Optionee an Option to purchase up to 58,750 Common Stock of the Company (collectively, the "Shares") in accordance with the terms of the ESOP; and
Made as of the 25 day of April, 2013Stock Option Agreement • April 26th, 2013 • OphthaliX, Inc. • Pharmaceutical preparations
on February 2, 2012 the shareholders of the Company approved the 2012 Stock Incentive Plan, a copy of which is attached as Exhibit A hereto (the "Plan"), on January 29, 2013 the Board of Directors of the Company has approved the Israeli Annex to the Plan to enable the grant of Options under Section 102 of the Israeli Tax Ordinance ("Section 102"), a copy of which is attached as Exhibit A hereto, forming an integral part hereof (the “ISOP”; the Plan and the ESOP shall collectively be referred to herein as the "ESOP"), and on April 22, 2013 the Board of Director of the Company has resolved to grant to the Optionee a Time Based Option to purchase up to 469,854 Common Stock of the Company and a Success Based Option to purchase up to 469,854 Common Stock of the Company (collectively, the "Shares") in accordance with the terms of the ESOP; and
